Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00192829

Enrollment

100

Registered

2005-09-19

Start date

2005-06-30

Completion date

Unknown

Last updated

2007-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Small Cell Lung Carcinoma, Venous Thromboembolism

Keywords

Lung cancer, Thrombosis, Hypercoagulable

Brief summary

The association between cancer and thrombosis is well known and the occurrence of thrombotic complications is commonly associated with poor prognosis. The aim os this study is to determine the possible value of hypercoagulable parameters as prognostic parameters in advanced non-small cell lung carcinoma (NSCLC).

Interventions

PROCEDUREBlood sample withdrawal

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Histologically or cytologically confirmed diagnosis of NSCLC. * normal serum bilirubin * informed concent to participate in the study

Exclusion criteria

* anticoagulant therapy * infectious disease

Countries

Israel

Contacts

Primary ContactGalit Sarig, Ph.D

g_sarig@rambam.health.gov.il+972-4-8543503

Backup ContactNissim Haim, M.D

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026